Nurses the key to caring for arthritis
Rheumatology nurses could be the answer to improving care for hundreds of thousands of Australians with inflammatory arthritis.
Around 1.7 million Australians suffer with chronic, inflammatory forms of arthritis, yet there is a severe shortage of the specialist nurses who are trained to help care for these patients.
The report Rheumatology nurses: Adding value to arthritis care looks at the evidence supporting the benefits of rheumatology nursing and assesses access to rheumatology nursing care in Australia. The report commissioned by Arthritis Australia, found that there was just one full-time rheumatology nurse for every 45,000 people living with painful and disabling conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, gout and juvenile arthritis.
“An increase in rheumatology nurses would mean quicker diagnoses, better psychosocial support for patients, improved quality of care, better patient outcomes and reduced health system costs,” Ms Cahill said. “Importantly, this research confirms that people who see a rheumatology nurse as part of their care are much more satisfied with all aspects of their care than those who do not.”
“Adding rheumatology nursing to the traditional care model which uses only a rheumatologist would mean quicker access to specialist care and an earlier start to treatment. Our report shows this would in turn mean an increase in the number of patients going into remission and a decrease in the average cost of care per patient,” said Ms Cahill.
“For these reasons, we call on the Federal, State and Territory governments to provide dedicated funding to train and employ more rheumatology nurses,” finished Ms Cahill.
Click here for the full media release.
Click here for the full report.Reviewed and updated October 2017
Australian Rheumatology Association and Arthritis Australia Statement regarding the use of glucosamine for the treatment of Osteoarthritis
Recent media reports have raised concern over the use of glucosamine in the treatment of osteoarthritis. These reports appear to be based on two unrelated...
UPDATED: Advice regarding Coronavirus (Covid-19) from the Australian Rheumatology Association
Due to the increasing number of infections in Australia from Coronavirus (Covid-19), we are aware of growing concerns raised by patients with chronic illnesses and...
Reducing opioid harm through regulatory changes – Information for consumers, patients and carers
The Australian Government, through the Therapeutic Goods Administration (TGA) within the Department of Health, is implementing a number of regulatory changes in order to minimise...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox: